Amlodipine as add-on to Olmesartan in Hypertension

Last updated: December 20, 2018
Sponsor: Sankyo Pharma Gmbh
Overall Status: Completed

Phase

3

Condition

Williams Syndrome

Diabetes And Hypertension

High Blood Pressure (Hypertension)

Treatment

N/A

Clinical Study ID

NCT00220220
CS8663-A-E302
  • Ages > 18
  • All Genders

Study Summary

Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Mean sitting BP of greater than or equal to 140/90-115 mmHg and mean 24h dBP greaterthan or equal to 80 mmHg with at least 30% of daytime readings greater than 85 mmHgprior to randomization.

Exclusion

Exclusion Criteria:

  • Secondary hypertension of any aetiology;

  • Any serious disorders which may limit the ability to evaluate the efficacy or safetyof the test drug(s);

  • History of myocardial infarction, unstable angina pectoris, percutaneous coronaryintervention, congestive heart failure, hypertensive encephalopathy, stroke or TIAwithin the last 6 months.

Study Design

Total Participants: 429
Study Start date:
April 01, 2005
Estimated Completion Date:
April 30, 2007

Connect with a study center

  • Hamburg,
    Germany

    Site Not Available

  • Magdeburg,
    Germany

    Site Not Available

  • Messkirch,
    Germany

    Site Not Available

  • Stuhr,
    Germany

    Site Not Available

  • Tann,
    Germany

    Site Not Available

  • Worpswede,
    Germany

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.